CompletedNot Applicable

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

United States27 participantsStarted 2021-01-01

Plain-language summary

This trial tests whether Planning for Your Advance Care Needs (PLAN) intervention works to enhance Latino patients' understanding of and engagement in advanced care planning. The PLAN intervention may be an effective method to help people with cancer plan for and talk about advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Identifying ethnically as Latino. * Locally advanced or metastatic cancer and/or have experienced disease progression on at least first-line chemotherapy. * Ability to provide informed consent. Exclusion Criteria: * Not fluent in English or Spanish. * Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of \>= 6 to be delivered by trained study research staff during screening). * Too ill or weak to complete the interviews (as judged by interviewer). * Currently receiving palliative care/hospice at the time of enrollment (to allow prediction of \[advanced care planning\] ACP). * Children and young adults under age 18. * Patients deemed inappropriate for the study by their treating oncologist.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Feasibility (Number/Proportion of Participants Who Completed the Intervention)

Timeframe: Five weeks post-randomization (for intervention arm only)

Acceptability (Helpfulness of the Intervention)

Timeframe: Five weeks post-randomization (for intervention arm only)

Change in Knowledge of Advance Care Planning

Timeframe: Baseline, five weeks post-randomization (after randomizing and completing the 3-week intervention if assigned)

Change in Readiness/Motivation to Engage in Advance Care Planning

Timeframe: Baseline, five weeks post-randomization (after randomizing and completing the 3-week intervention if assigned)

Change in Self-efficacy to Engage in Advance Care Planning

Timeframe: Baseline, five weeks post-randomization (after randomizing and completing the 3-week intervention if assigned)

Change in Engagement in Advance Care Planning (End-of-life Care Discussions)

Timeframe: Baseline, five weeks post-randomization (after randomizing and completing the 3-week intervention if assigned)

Trial details

NCT IDNCT04889144

SponsorFred Hutchinson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-12

Results submitted2025-07-01

View on ClinicalTrials.gov More Locally Advanced Malignant Solid Neoplasm trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Feasibility (Number/Proportion of Participants Who Completed the Intervention)

Timeframe: Five weeks post-randomization (for intervention arm only)

Acceptability (Helpfulness of the Intervention)

Timeframe: Five weeks post-randomization (for intervention arm only)

Change in Knowledge of Advance Care Planning

Timeframe: Baseline, five weeks post-randomization (after randomizing and completing the 3-week intervention if assigned)

Change in Readiness/Motivation to Engage in Advance Care Planning

Timeframe: Baseline, five weeks post-randomization (after randomizing and completing the 3-week intervention if assigned)

Change in Self-efficacy to Engage in Advance Care Planning

Timeframe: Baseline, five weeks post-randomization (after randomizing and completing the 3-week intervention if assigned)

Change in Engagement in Advance Care Planning (End-of-life Care Discussions)

Timeframe: Baseline, five weeks post-randomization (after randomizing and completing the 3-week intervention if assigned)